Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Renal Cell | 6 | 2022 | 435 | 2.550 |
Why?
|
| Kidney Neoplasms | 7 | 2023 | 635 | 2.460 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2022 | 185 | 1.700 |
Why?
|
| Biomarkers, Tumor | 9 | 2024 | 1543 | 1.210 |
Why?
|
| Th2 Cells | 5 | 2017 | 147 | 1.130 |
Why?
|
| Dendritic Cells | 5 | 2015 | 442 | 1.010 |
Why?
|
| Receptors, IgG | 2 | 2014 | 53 | 0.900 |
Why?
|
| Eosinophils | 1 | 2020 | 194 | 0.680 |
Why?
|
| Mesothelioma | 4 | 2023 | 323 | 0.650 |
Why?
|
| Leiomyoma | 1 | 2022 | 200 | 0.650 |
Why?
|
| Interleukins | 4 | 2014 | 129 | 0.590 |
Why?
|
| Hypersensitivity | 2 | 2014 | 158 | 0.520 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 754 | 0.470 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 86 | 0.470 |
Why?
|
| Mutation | 5 | 2024 | 4132 | 0.450 |
Why?
|
| Inflammation | 4 | 2014 | 971 | 0.400 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1521 | 0.370 |
Why?
|
| Signal Transduction | 4 | 2014 | 3374 | 0.350 |
Why?
|
| Lung | 2 | 2013 | 1258 | 0.340 |
Why?
|
| Pleural Neoplasms | 2 | 2023 | 198 | 0.320 |
Why?
|
| Prognosis | 5 | 2024 | 3773 | 0.320 |
Why?
|
| Neoplasms | 1 | 2024 | 3035 | 0.310 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 738 | 0.290 |
Why?
|
| Blood Glucose | 1 | 2011 | 836 | 0.290 |
Why?
|
| Humans | 26 | 2024 | 89073 | 0.290 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 2347 | 0.250 |
Why?
|
| Interleukin-33 | 2 | 2014 | 25 | 0.230 |
Why?
|
| Gastritis, Atrophic | 1 | 2023 | 4 | 0.230 |
Why?
|
| Genomics | 3 | 2024 | 761 | 0.230 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2023 | 31 | 0.220 |
Why?
|
| Gastritis | 1 | 2023 | 36 | 0.220 |
Why?
|
| Angiomyolipoma | 1 | 2023 | 17 | 0.220 |
Why?
|
| Hamartoma | 1 | 2023 | 34 | 0.220 |
Why?
|
| Vanadates | 1 | 2023 | 32 | 0.210 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2013 | 63 | 0.210 |
Why?
|
| Hemolysis | 1 | 2023 | 64 | 0.210 |
Why?
|
| Middle Aged | 8 | 2024 | 25865 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 3211 | 0.210 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2023 | 49 | 0.210 |
Why?
|
| Peritoneal Neoplasms | 1 | 2023 | 184 | 0.200 |
Why?
|
| Neurofibromin 2 | 1 | 2022 | 30 | 0.200 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2022 | 29 | 0.200 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 65 | 0.200 |
Why?
|
| Meningioma | 1 | 2022 | 63 | 0.200 |
Why?
|
| Lymphoma, T-Cell | 1 | 2022 | 55 | 0.200 |
Why?
|
| Sarcoma | 1 | 2023 | 220 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 412 | 0.190 |
Why?
|
| Platelet Aggregation | 1 | 2021 | 44 | 0.190 |
Why?
|
| Asthma | 3 | 2015 | 976 | 0.190 |
Why?
|
| Formaldehyde | 1 | 2021 | 52 | 0.190 |
Why?
|
| Female | 14 | 2024 | 46014 | 0.190 |
Why?
|
| Thrombin | 1 | 2021 | 61 | 0.190 |
Why?
|
| Keratin-20 | 1 | 2020 | 7 | 0.190 |
Why?
|
| Lymphoma, B-Cell | 1 | 2022 | 106 | 0.190 |
Why?
|
| Keratin-7 | 1 | 2020 | 10 | 0.190 |
Why?
|
| Vimentin | 1 | 2020 | 46 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 196 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2021 | 150 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 481 | 0.180 |
Why?
|
| Cytokines | 2 | 2014 | 802 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2023 | 9003 | 0.180 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 205 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 14 | 0.180 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 316 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2023 | 1796 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2020 | 84 | 0.170 |
Why?
|
| Leukemia | 1 | 2022 | 323 | 0.170 |
Why?
|
| Male | 9 | 2024 | 42254 | 0.170 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2021 | 170 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 26508 | 0.160 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2017 | 18 | 0.150 |
Why?
|
| Necrosis | 1 | 2018 | 209 | 0.150 |
Why?
|
| Interleukin-5 | 1 | 2017 | 36 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 395 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 788 | 0.140 |
Why?
|
| Acute Lung Injury | 1 | 2017 | 64 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 1108 | 0.140 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 372 | 0.130 |
Why?
|
| Liver | 1 | 2021 | 1205 | 0.130 |
Why?
|
| Melanoma | 1 | 2020 | 467 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2017 | 1990 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 27324 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 262 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2017 | 471 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2014 | 1652 | 0.120 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2014 | 11 | 0.120 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2014 | 12 | 0.120 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 36 | 0.120 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 196 | 0.120 |
Why?
|
| Mice | 5 | 2017 | 11742 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 87 | 0.120 |
Why?
|
| Immunization | 1 | 2014 | 160 | 0.120 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 751 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 169 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2014 | 84 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2014 | 166 | 0.110 |
Why?
|
| Monocytes | 1 | 2015 | 218 | 0.110 |
Why?
|
| Allergens | 1 | 2014 | 183 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2023 | 65 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 70 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3657 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 69 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2015 | 338 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 374 | 0.100 |
Why?
|
| Young Adult | 2 | 2023 | 6289 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 207 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 727 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 19078 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 691 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 464 | 0.090 |
Why?
|
| Bacteria | 1 | 2014 | 472 | 0.090 |
Why?
|
| Macrophages | 1 | 2013 | 571 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2552 | 0.080 |
Why?
|
| Career Choice | 1 | 2011 | 148 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 9237 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 6777 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1149 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2011 | 758 | 0.060 |
Why?
|
| Exodeoxyribonucleases | 1 | 2023 | 17 | 0.060 |
Why?
|
| Peritoneum | 1 | 2023 | 57 | 0.060 |
Why?
|
| Biology | 1 | 2023 | 52 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2023 | 33 | 0.050 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2023 | 24 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2023 | 84 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2023 | 55 | 0.050 |
Why?
|
| Bilirubin | 1 | 2023 | 129 | 0.050 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Phenotype | 2 | 2022 | 2439 | 0.050 |
Why?
|
| Bias | 1 | 2023 | 131 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 313 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 287 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2011 | 1041 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 53 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2021 | 39 | 0.050 |
Why?
|
| Platelet Count | 1 | 2021 | 93 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2022 | 519 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2020 | 61 | 0.040 |
Why?
|
| Intestines | 2 | 2014 | 416 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1182 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 307 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2020 | 237 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 578 | 0.040 |
Why?
|
| Kidney | 1 | 2023 | 1145 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 665 | 0.040 |
Why?
|
| Bleomycin | 1 | 2017 | 102 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1975 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 859 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 599 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 23 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2014 | 46 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 2335 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2015 | 55 | 0.030 |
Why?
|
| Mites | 1 | 2013 | 16 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 524 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 151 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2880 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 47 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8203 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7149 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 173 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 429 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 695 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 387 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 688 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2362 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 375 | 0.020 |
Why?
|
| Microbiota | 1 | 2014 | 398 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1574 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 786 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2011 | 355 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Pediatrics | 1 | 2011 | 352 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 805 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1223 | 0.020 |
Why?
|